Imbio PHA (4.0.0) vs Study Watch
AI Verdict
Choose Imbio PHA (4.0.0) if…
Choose Imbio PHA if your primary need is rapid, automated analysis of existing CT pulmonary angiogram (CTPA) scans to assess cardiac structures. This tool is ideal for aiding in the diagnosis and risk stratification of conditions like pulmonary embolism and hypertension by providing quantitative measurements and ratios of the right ventricle, left ventricle, main pulmonary artery, and aorta. It integrates seamlessly into radiology workflows, delivering actionable insights from imaging data.
View Imbio PHA (4.0.0) →Choose Study Watch if…
Choose Verily Study Watch if your objective is continuous, long-term physiological data collection for clinical research or remote monitoring of patients. This prescription-only wearable device is best suited for studies requiring extended monitoring of parameters such as ECG, heart rate, and movement, providing a rich dataset for analysis in a cloud-based platform. It enables the capture of real-world physiological data outside of a clinical setting, which is crucial for understanding disease progression or treatment efficacy over time.
View Study Watch →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Imbio PHA (4.0.0) | Study Watch |
|---|---|---|
| Pricing | Contact for pricing | Not publicly available (device for clinical research and partnerships) |
| Deployment | Cloud, Enterprise (on-premise), or via partners | Cloud (data uploaded from device to Verily's cloud platform). |
| FDA Status | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Imbio PHA (4.0.0)Imbio PHA is designed for seamless integration into existing clinical imaging workflows, directly providing actionable insights within familiar systems like PACS. Its rapid, automated assessment minimizes disruption and learning curve for healthcare professionals.
Clinical Value
TieBoth tools offer significant clinical value through their FDA-cleared functionalities. Imbio PHA provides immediate diagnostic and risk stratification insights for acute conditions like pulmonary embolism, while Verily Study Watch offers continuous physiological monitoring crucial for long-term management and clinical research, including detection of irregular pulse and atrial fibrillation.
Pricing & Value
TieNeither company publicly discloses pricing information, making a direct comparison of their cost-effectiveness or overall value impossible. Both require direct contact for pricing details, and Verily Study Watch is primarily for clinical research and partnerships, not individual sale.
Enterprise Readiness
Imbio PHA (4.0.0)Imbio PHA offers greater deployment flexibility with options for cloud, on-premise, or partner integration, which is critical for diverse enterprise IT environments. While both claim HIPAA compliance, the ongoing lawsuit alleging HIPAA violations against Verily, even if denied, introduces a potential risk factor for enterprise adoption.
Innovation
Study WatchVerily Study Watch demonstrates a higher degree of innovation by introducing a prescription-only wearable for continuous multi-sensor physiological monitoring, enabling novel data collection for clinical research and patient management. This represents a more disruptive approach to healthcare data acquisition compared to Imbio PHA's enhancement of existing imaging workflows.
Support & Docs
Study WatchWhile both companies offer support, Verily provides more explicit public-facing resources for documentation and support for its various products, including specific regulatory information PDFs for the Study Watch and charging dock, and resources for its Data Workbench. Imbio's public support information is more general, directing users to contact them for specific manuals.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Imbio PHA (4.0.0) | Study Watch |
|---|---|---|
| Product Name | Imbio PHA (4.0.0) | Study Watch |
| Product Type | AI-powered medical image processing software | Prescription-only, sensor-based wearable device |
| Primary Functionality | Automated measurement of cardiac structures from CTPA scans for pulmonary embolism and hypertension assessment | Continuous physiological monitoring (ECG, heart rate, movement) for clinical research |
| Target Medical Specialties | Cardiology, Pulmonology, Radiology | Cardiology, Neurology, Sleep Medicine |
| Key Data Collected/Analyzed | Right and left ventricle diameters, main pulmonary artery and aorta diameters, RV/LV and PA/Ao ratios | ECG, heart rate, electrodermal activity, inertial movements |
Videos
Demos, reviews, and walkthroughs featuring Imbio PHA (4.0.0) and Study Watch.